YIH
VIGL

Y-Intercept (HK)’s Vigil Neuroscience VIGL Stock Holding History

Y-Intercept (HK)’s Portfolio VIGL Stock Details VIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-38,364
Closed -$153K – 1836
2024
Q2 		$153K Buy
+38,364
New +$131K 0.01% 1211

Other funds holding VIGL

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
NV
Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Y-Intercept (HK)'s VIGL Position: Q3 2024 in Review

Y-Intercept (HK) sold out of Vigil Neuroscience (VIGL) in Q3 2024, closing a stake of 38,364 shares — an estimated $153K sold.

Y-Intercept (HK) first reported a position in VIGL in Q2 2024 and held it in 1 quarter. The position peaked at $153K in Q2 2024. 52 funds tracked by Wall St. Rank hold VIGL as of Q3 2024.

  • Y-Intercept (HK) reported no remaining Vigil Neuroscience position as of Q3 2024 after selling out during the quarter.
  • Y-Intercept (HK) sold 38,364 Vigil Neuroscience shares in Q3 2024, an estimated $153K.
  • Y-Intercept (HK) first reported a position in Vigil Neuroscience in Q2 2024 and held it in 1 quarter.
  • Y-Intercept (HK)'s Vigil Neuroscience position peaked at $153K in Q2 2024.
  • 52 funds tracked by Wall St. Rank held Vigil Neuroscience as of Q3 2024.

Based on Y-Intercept (HK)'s 13F filing for Q3 2024, filed 15 Nov 2024.